ecrin-mdr-crcClinical2010unresectable metastatic colorectal cancerUnresectable Metastatic Colorectal CancerInterventionalhttps://newmdr.ecrin.org/Study/2620026Japan11ECRIN MDRRecruitingfalsePhase 1/2 study of cetuximab plus capecitabine in elderly patients with kras-wild type mCRC who have no prior chemotherapyInterventions: capecitabine,cetuximab Primary outcome(s): Safety/efficacy Study Design: Single arm Non-randomized2010-11-152620026JPRN-UMIN000004579